Skip to main content
. 2020 Jan 17;13(1):16. doi: 10.3390/ph13010016

Table 3.

Yields and preliminary cell viability data for compounds 17an, 18 (Series IIIB) in MUTU-1 and DG-75 Burkitt lymphoma cell lines a.

graphic file with name pharmaceuticals-13-00016-i003.jpg MUTU-1 Cell Viability % DG-75 Cell Viability %
Compound n Substitution Yield (%) 10 μM 1 μM 10 μM 1 μM
17a 0 R1=R3=R4=R5=R6=H, R2=CH3 88 68.6 79.8 88.9 78.3
17b 0 R1=R3=R4=R5=R6=H, R2=CH2CH3 82 83.4 92.6 99.9 96.4
17c 0 R1=R3=R4=R6=H, R5=Cl, R2=CH3 60 77.6 78.0 86.3 96.6
17d 0 R1=R3=R4=R6=H, R5=Cl, R2=CH2CH3 44 99.9 102.0 78.4 96.6
17e 0 R1=R3=R4=R6=H, R5=OCH3, R2=CH3 65 91.1 84.2 100.4 82.8
17f 0 R1=R3=R4=R6=H, R5=OCH3, R2=CH2CH3 54 84.5 86.5 85.1 91.4
17g 0 R1=Cl, R3=R4=R5=R6=H, R2=CH3 39 78.5 88.0 84.3 85.3
17h 0 R1=Cl, R3=R4=R5=R6=H, R2=CH2CH3 38 96.3 106.7 90.3 89.2
17i 1 R1=R3=R4=R5=R6=R2=H 74 0.86 74.9 0.67 93.1
17j 1 R1=R3=R4=R5=R6=H, R2=CH3 62 85.6 94.6 87.9 103.6
17k 1 R1=R3=R4=R5=R6=H, R2=CH2CH3 50 94.0 80.4 96.0 74.8
17l 1 R1=R3=H, R4=R5=R6=OCH3, R2=CH3 45 77.3 66.8 82.1 81.9
17m 1 R1=R3=H, R4=R5=R6=OCH3, R2=CH2CH3 54 66.8 82.2 77.8 82.2
17n 2 R1=R3=R4=R5=R6=R2=H 77 2.0 2.8 0.070 19.9
18 0 - 68 13.2 75.0 13.2 87.3
Maprotiline
8
- - - 73.0 93.1 65.1 102.0
Taxol - - - 9.8 30.4 9.9 48.8

a Cell proliferation of MUTU-1 and DG-75 cells was determined with an alamarBlue assay (seeding density 1–5 × 104 cells/mL per well for 96-well plates). Compound concentrations of either 1 μM or 10 μM for 24 h (MUTU-1) or 48 h (DG-75) were used to treat the cells (in triplicate) with control wells containing vehicle ethanol (1% v/v). The mean value for three experiments is shown.